Some two decades will shortly have passed since the WTO's Trade
Related Aspects of Intellectual Property Rights agreement came into
force in 1995. TRIPS is widely considered to have had a negative
impact on access to medicines through its rules on pharmaceutical
patents. This volume is the first cross-country analysis of how
TRIPS has affected the capacity of 11 major low or medium income
countries to produce generic drugs and assesses the wider political
economy of drug production and consumption in the Global South.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!